Trials / Completed
CompletedNCT06581263
Psychedelic Virtual Reality
Investigating the Use of Virtual Reality in Psychedelic Research or Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate a novel VRP.
Detailed description
The primary objective of this study is to determine whether the subjective experience of a novel VRP (DeepDream) will be comparable to a standard dose of psychedelics. This study also looks to compare the subjective experience of DeepDream VRP to other available VR modalities developed to mimic psychedelic subjective experience along with assessing the incidence of VRP adverse effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Meta Quest 3 | Meta Quest 3 is a virtual reality headset device |
Timeline
- Start date
- 2025-07-22
- Primary completion
- 2026-03-22
- Completion
- 2026-03-22
- First posted
- 2024-09-03
- Last updated
- 2026-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06581263. Inclusion in this directory is not an endorsement.